SRNA Research Initiative

About Ainos

Ainos is a publicly traded medtech company undergoing a strategic transformation from its 1984 roots in low-dose interferon research into a diversified AI-driven healthcare player. Its core technology platform is the 'AI Nose,' a semiconductor-based sensor array that analyzes VOCs from breath and other samples to create a digital 'Smell ID' for disease detection. The company's pipeline includes rapid diagnostic tests for COVID-19 and pneumonia, a non-invasive feminine health test, and several clinical-stage low-dose interferon programs for conditions like thrombocytopenia and Sjögren's Syndrome. With over 60 patents and a focus on telehealth-friendly devices, Ainos aims to commercialize its platforms in the growing digital health and point-of-care testing markets.

Therapeutic Areas